Conference abstract · 24 Mar 2014
Conference abstractPublished 20 Oct 2014
Oxytocin and#305;mproves follicular reserve in a cisplatin-and#305;nduced gonadotoxicity model in rats
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cis-Diamminedichloroplatinum (II)(cisplatin, CP) is an antitumor agent effective for treating various human cancers of the breast, brain, head and neck, stomach, lung, bladder, testis, and ovary. Its anti-tumor activity is attributed mainly to its ability to form platination products in the nuclear DNA. However, repetitive treatment with CP is associated with numerous side effects such as nephrotoxicity, neurotoxicity, and reproductive toxicity. In both animal and human studies, CP has been shown to cause ovarian injury, leading to ovarian dysfunction, changes in the estrous cycle, increased follicular apoptosis, and a reduction in the number of anti-Mullerian hormone-(AMH) secreting follicles. Oxytocin (OT), a nonapeptide produced in the paraventricular and supraoptic nuclei in the hypothalamus, is essentially associated with uterine contraction during parturition and milk ejection reflex during lactation. OT receptors (OTR) have been demonstrated not only in the uterine and myoepithelial tissues, but also in other tissues, including heart, thymus, kidney, pancreas, adipose tissue, and ovaries. Accumulating evidence suggests that OT exerts its cytoprotective effects via antioxidative, antiapoptotic, and anti-inflammatory pathways. Recently, we have shown its beneficial effects against sepsis-induced polyneuropathy, pentylenetetrazol-induced seizures, and rotenoneinduced Parkinson?s disease model in rats. Although several studies have demonstrated the protective role of OT in various types of tissue injury, there is still lack of data with regard to beneficial effects of this peptide in chemotherapy-induced ovarian gonadotoxicity. Therefore, we conducted the present study to explore whether OT has protective effects on follicle reserve in a CP-induced gonadotoxicity model in rats by evaluating histopathological alterations, plasma AMH levels, and ovary malondialdehyde (MDA) and glutathione (GSH) levels as markers of oxidative stress.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 21 Oct 2013
Efficacy of different regimens of intraperitoneal chemoperfusions with cisplatin in a rat model of ovarian cancer peritoneal carcinomatosis
Research article · 2013
The Effect of Bone Marrow Transplantation on Oocyte-Granulosa Cell Interaction and Follicular Development of Cisplatin-Induced Ovarian Failure in Rat
Conference abstract · 12 Nov 2012
The role of bone marrow transplantation on oocyte-granulosa cell interaction and follicular development of cisplatin-induced ovarian failure in rat
Research article · 30 Jul 2020
Safe Combination of Cisplatin and Metformin Reverts the Malignant Ascites in a Mouse Model to a Solid Tumor by Downregulation of ΔNp63 and Induces Tumor Dormancy via m TOR/ p21 Mechanism
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Oytun Erbas”

